cDNA Clone & Molecular Biology Supply

The contract pertains to the supply of cDNA clones encoding engineered antibody sequences for preclinical development, encompassing full molecular biology services from vector design through cloning and rigorous sequence validation. The work is required to deliver high-quality, accurately engineered genetic constructs that meet precise specifications for use in advancing therapeutic antibody candidates, ensuring reliability and reproducibility in downstream preclinical applications. All deliverables must be fully characterized and validated to confirm sequence fidelity and functional integrity. The solicitation, issued under the National Institutes of Health Office of Laboratory Animal Welfare within the Department of Health and Human Services, is a subcontract with a place of performance in Bethesda, Maryland, and carries the NAICS code 325412 for biological product manufacturing. Interested parties must submit responses by August 3, 2026, and the opportunity is open without specific set-aside classifications. The technical scope demands expertise in molecular cloning, antibody engineering, and quality control, with expectations for timely delivery and strict adherence to validated protocols to support rigorous preclinical timelines.